
Sudeep Pharma Limited Appoints Milin Mehta as Additional Non-Executive Director
Sudeep Pharma Limited has appointed Mr. Milin Mehta as an Additional Director in the category of Non-Executive Non-Independent Director, effective from June 26, 2026. The appointment was finalized during a Board meeting held on Friday, June 26, 2026.Mr. Mehta, who is liable to retire by rotation, assumes the role subject to the approval of the company's shareholders.
Director Profile and Background
The appointment brings Mr. Milin Mehta, a Chartered Accountant and Law Graduate, into Sudeep Pharma Limited’s board. He currently serves as the Managing Partner at K C Mehta&Co LLP, where he has been a pivotal figure in the firm's growth over more than three decades.Mr. Mehta possesses extensive expertise across accounting, legal matters, and strategic advisory roles. He is noted for securing a rank in the CA exams and receiving a Gold Medal in M.Com from The Maharaja Sayajirao University of Baroda. Under his leadership at the firm, he has focused on establishing the International Tax and Transfer Pricing practice and leads the Transaction Advisory Services vertical while guiding the Tax and Regulatory practice. His experience includes representing clients in complex tax litigation.
Beyond his professional roles, Mr. Mehta is a recognized voice in the accounting profession. He was invited by the Government of India and CBDT to contribute to key national policy initiatives, including the formulation of Income Computation and Disclosure Standards (ICDS) and evaluating Minimum Alternate Tax under Ind-AS. He has served as the Vice Chairman and Treasurer of the Western India Regional Council of ICAI. Mr. Mehta has also authored a co-authored book on Minimum Alternate Tax.
He serves as an Independent Director on the boards of various listed and unlisted companies across different sectors, chairing several audit and governance committees. In addition to his business commitments, he is involved in education and social causes, having served on the Senate and Syndicate of The Maharaja Sayajirao University of Baroda.
Mr. Mehta holds no relationship with any Director of Sudeep Pharma Limited as defined under Section 2(77) of the Companies Act, 2013.
SUDEEPPHRM Stock Price Movement
On Thursday, Sudeep Pharma Limited shares shed 4.64% of their value to settle at ₹809.2. The stock recorded a volume of 228,620 shares during the decline.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.